Who owns ABIOMED?

Key details on ABIOMED (Ticker: ABMD)

Who owns ABIOMED?

Is ABMD a good stock to own? Find out who bought ABIOMED, who sold ABIOMED (ABMD) stock, and who holds a large position in ABIOMED.

Fund Name Number of Shares Share Valuation As Of
PRIMECAP Management Company 5.75M $149.78M March 31, 2014
Macquarie 5.38M $139.97M March 31, 2014
Essex Woodlands Health Ventures 3.15M $82.03M March 31, 2014
William Blair $ Company 2.66M $69.25M March 31, 2014
Vanguard 2.41M $62.90M March 31, 2014
Palo Alto Investors 2.20M $57.35M March 31, 2014
BlackRock Fund Advisors 2.09M $54.38M March 31, 2014
Next Century Growth Investors 1.76M $45.87M March 31, 2014
Blue Mountain Capital Management 1.61M $41.87M March 31, 2014
Wellington Management Company 1.60M $41.58M March 31, 2014
BlackRock Institutional Trust Company, N.A. 1.08M $28.04M March 31, 2014
Allianz Global Investors of America 903050 $20.04M March 31, 2012
Millennium Management 841173 $21.90M March 31, 2014
CR Intrinsic Investors 800000 $14.94M March 31, 2013
Royal Bank of Canada 766073 $20.22M March 31, 2014
STATE STREET CORPORATION 746293 $19.43M March 31, 2014
Arbor Capital Management 640400 $14.21M March 31, 2012
Geneva Capital Management 634846 $16.53M March 31, 2014
OMT Capital Management 632350 $16.91M Dec. 31, 2013
NORTHERN TRUST 580300 $15.51M Dec. 31, 2013
CITADEL ADVISORS 556618 $10.39M March 31, 2013
Loomis, Sayles and 544770 $11.43M Sept. 30, 2012

Who sold ABIOMED?

Fund Name Date Sold Number of Shares Sold Share Valuation
----------------------------------------------------------------------------- Dec. 31, 2012 563603 $7.59M
Adage Capital Partners GP Sept. 30, 2011 600000 $6.62M
Columbus Circle Investors June 30, 2011 943204 $15.28M
Pier Capital June 30, 2011 564096 $9.14M
Norges Bank Investment Management March 31, 2011 1.17M $17.02M
Portolan Capital Management March 31, 2011 1.10M $15.92M